Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,045
Sort by:
Cyclin-dependent-kinase-inhibitors - Pipeline Insight, 2022
US$ 2,500.00
This report can be delivered to the clients within 3-4 working days DelveInsight’s, “Cyclin-dependent-kinase-inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 40+ com...
January 2022
150 pages
VAP-1 Inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “VAP-1 Inhibitors- Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline dru...
January 2022
60 pages
Anti-CD22 Therapies - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Anti-CD22 Therapies - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline...
January 2022
60 pages
Anti-CD30 Therapies - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Anti-CD30 Therapies - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline...
January 2022
60 pages
AXL Kinase Inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “AXL Kinase Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipelin...
January 2022
60 pages
LRRK2 Inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2021,” report provides comprehensive insights about 8+...
January 2022
60 pages
TGFb inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “TGF-Beta Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline...
January 2022
60 pages
TIM-3 Inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “TIM-3 Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline dru...
January 2022
60 pages
Dopamine D2 receptor antagonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Dopamine D2 receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and...
January 2022
60 pages
GABA A receptor agonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “GABA A receptor agonist - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipe...
January 2022
60 pages
Interleukin-33 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Interleukin-33 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 7+ companies and 7+ pipe...
January 2022
60 pages
P selectin inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “P selectin inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+ pipeline...
January 2022
60 pages
Potassium channel antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Potassium channel antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10...
January 2022
60 pages
Serotonin receptor 2 angonist - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Serotonin receptor 2 Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ p...
January 2022
60 pages
14-alpha demethylase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and...
January 2022
60 pages
22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's '22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
3C-like-proteinase inhibitors- Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “3C-like-proteinase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+...
January 2022
60 pages
Abdominal Aneurysms - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abdominal Aneurysms - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Abdominal Aortic Aneurysm - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abdominal Aortic Aneurysm - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Abscess - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Abscess - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and...
January 2022
60 pages
Acanthamoeba Keratitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Acanthamoeba Keratitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
ACE/ARB Inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “ACE/ARB Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline dr...
January 2022
60 pages
Acetyl-CoA carboxylase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and...
January 2022
60 pages
Achondroplasia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Achondroplasia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
